HEMEX Benelux

Vital Decosterstraat 16

3000 Leuven

BE

HEMEX Benelux

Foundation date

01/09/2023

Sector

#Biotechnology / R&D Services

Subsector

Therapeutic areas

HEMEX, a CRO, provides clinical development services for healthcare SMEs, covering phases from late pre-clinical to phases I-IV, CE-mark applications, and post-market clinical investigations. Our extensive track record encompasses diverse therapeutic areas, including pharmaceuticals, biotechnology, medical devices, IVDs, and digital health. Collaborating with universities, hospitals, professionals, patient groups, and corporations, we have excelled in clinical, regulatory, and quality projects.

Upcoming events

Latest news

  • Bio Base Europe Pilot Plant successfully commissions a 75,000 L fermenter, demonstrating Vivici’s Vivitein™ BLG technology in industrial-scale precision fermentation

    9 hours ago

  • argenx Advances Clinical Development of Efgartigimod SC in Idiopathic Inflammatory Myopathies

    1 day ago

  • ExeVir Announces Michael Garrett as New Chief Executive Officer

    Tuesday November 19th 2024